← Latest Filings
M
Matrix Capital Management Company, LP
Also a 13F filer: see its fund portfolio and quarterly moves →
Open-market buys
0
$0 total
Open-market sells
2
$49.0M total
Tracking since
Dec 2025
Activity timeline
Open-market sale — $39.0M
Aura Biosciences, Inc. · May 7, 2026
Open-market sale — $10.0M
Zentalis Pharmaceuticals, Inc. · Dec 15, 2025
Open-market trades from the last two years.
Holdings as last reported
6,459,973 Common Stock, par value $0.001 per share in ZNTL
Held indirectly (See footnotes) · as of 2025-12-15
Companies touched
Aura Biosciences, Inc.
CIK 0001501796
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
